The objective of this study is to evaluate safety and performance of the COOLSTAT® Transnasal Thermal Regulating Device in reducing temperature in a population of febrile subjects who meet the inclusion/exclusion criteria.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
30
Placement of transnasal thermal regulating device to reduce temperature in febrile patients for a period of 8 to 24 hours
MedStar Washington Hospital Center
Washington D.C., District of Columbia, United States
University of Maryland Medical Center
Baltimore, Maryland, United States
University of Texas, Houston
Houston, Texas, United States
Cooling Performance
Ability of transnasal thermal regulating device to reduce core body temperature within 4 hours of initiation
Time frame: 4 hours
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.